Keywords: Epigenetic writers, readers, and erasers, modifiers of histone, DNA, and RNA, non-coding RNA, vascular disease, mechanism, pharmacological or genetic intervention, technologies to aid translation, Epigenetic therapy vascular disease, Non-coding RNA cardiovascular, Vascular cell gene regulation, Histone modification vascular therapy, DNA methylation cardiovascular disease, Epigenetic biomarkers vascular health, Translational medicine epigenetics, Epigenetic drug targets vascular, Chromatin remodeling cardiovascular, Therapeutic epigenetics in vascular diseases, RNA methylation cardiovascular disease
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.